AGP Picks
View all

Iowa Healthcare Reporter
Provided by AGP

Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 27, 2026

Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 27, 2026

Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
May 27, 2026

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity

Indeterminate GlobeNewswire
New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026
May 27, 2026

New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026

Indeterminate GlobeNewswire
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes
May 27, 2026

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes

Indeterminate GlobeNewswire
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
May 27, 2026

HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen

Indeterminate GlobeNewswire
Transforming Rural Health Care Through a First-of-its-Kind Collaborative
May 27, 2026

Transforming Rural Health Care Through a First-of-its-Kind Collaborative

Indeterminate GlobeNewswire
Medline announces participation in upcoming investor conferences
May 27, 2026

Medline announces participation in upcoming investor conferences

Indeterminate GlobeNewswire
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
May 27, 2026

BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9

Indeterminate GlobeNewswire
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
May 27, 2026

Context Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial
May 27, 2026

TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial

Indeterminate GlobeNewswire
Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043
May 27, 2026

Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043

Indeterminate GlobeNewswire
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
May 27, 2026

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease

Indeterminate GlobeNewswire
Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics
May 27, 2026

Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics

Indeterminate GlobeNewswire
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
May 27, 2026

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Invivyd to Participate in Upcoming Investor Events
May 27, 2026

Invivyd to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire
MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions
May 27, 2026

MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
May 27, 2026

Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026

Indeterminate GlobeNewswire
L’Association canadienne de dermatologie, en partenariat avec Mélanome Canada, offrira des dépistages gratuits du cancer de la peau sur la Colline du Parlement
May 27, 2026

L’Association canadienne de dermatologie, en partenariat avec Mélanome Canada, offrira des dépistages gratuits du cancer de la peau sur la Colline du Parlement

Indeterminate GlobeNewswire
Canadian Dermatology Association in Partnership with Melanoma Canada Offer Free Skin Cancer Screenings on Parliament Hill
May 27, 2026

Canadian Dermatology Association in Partnership with Melanoma Canada Offer Free Skin Cancer Screenings on Parliament Hill

Indeterminate GlobeNewswire
Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
May 27, 2026

Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Iowa Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.